Sales, R&D and Manufacturing Facility 55A & 53B Fawcett Road, Coquitlam BC V3K 6V2 Canada
Zika IgG/IgM Ab Rapid Test
Biocan is pleased to announce the launch of Tell Me Fast Zika IgG/IgM Antibody test capable of detecting Zika Virus infection is just 5 minutes in human serum, plasma or whole blood samples. The test is easy to perform and does not require any special machines to run the test. Test can be performed at doctor's clinic, emergency rooms, patient's bedside, laboratories, field settings and point of care.
Easy to use and fast results in just minutes
Small volume of serum, plasma or whole blood required
No cross reactivity with Dengue & Chikungunya virus infection
100% specificity and 92% sensitivity
BIOCAN TELL ME FAST Zika Virus IgG/IgM Antibody Rapid Test is a qualitative lateral flow immunoassay for the simultaneous detection and differentiation of IgG and IgM antibodies to Zika Virus in human serum, plasma or whole blood. This test can be used for the presumptive distinction between a primary and secondary Zika Virus infection.
About Zika Virus & Summary:
Zika virus (ZIKV) is a mosquito-borne flavivirus that was first isolated from a rhesus monkey in the Zika forest of Uganda in 1947. In 1968, isolation from human hosts occurred in residents of Nigeria. Since then, multiple studies have confirmed ZIKV antibody in humans from a multitude of countries in Africa and parts of Asia. In 2015, ZIKV first appeared outside of Africa and Asia when it was isolated in Brazil where is has caused a minor outbreak following the 2014 FIFA World Cup. ZIKV is closely related to other mosquito-borne flaviviruses such as the dengue, yellow fever, West Nile, and Japanese encephalitis viruses. ZIKV causes a disease known as Zika fever, which is characterized by a macropapular rash covering the body, fever, joint pain, and malaise. Although there have yet to be serious complications arising from ZIKV, it's appearance across the globe, mosquito-driven transmission cycle, and possible spread via sexual contact make ZIKV an important emerging pathogen whose global impact is yet to be discovered. Diagnosis for ZIKV infection include PCR tests to detect viral DNA as well as additional tests to detect ZIKV antibody (IgM) in serum. IgM for ZIKV is typically detectable around 3-5 days after infection, but cross-reactivity with closely related dengue, yellow fever, Japanese encephalitis, and West Nile viruses are possible. These cross-reactive results were more common in patients that denoted signs of previous flavivirus infection than patients with primary ZIKV infection. For best diagnosis practices, serum samples should be analyzed as early as possible with a second test 2 to 3 weeks after that.